Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Complement in antibody-based tumor therapy
Stefanie Derer
*
, Frank J. Beurskens, Thies Rösner, Matthias Peipp, Thomas Valerius
*
Corresponding author for this work
Institute of Nutrition Medicine
Clinic of Internal Medicine I
Genmab B.V., Netherlands
University of Kiel
20
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Complement in antibody-based tumor therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Complement Dependent Cytotoxicity
100%
Therapeutic Antibodies
60%
Antibody-Dependent Cell-Mediated Cytotoxicity
40%
Tumor Cell
40%
Complement Activation
20%
Monoclonal Antibody
20%